Effect of Intraoperative Glucose Fluctuation and Postoperative IL-6, TNF-α, CRP Levels on the Short-term Prognosis of Patients with Intracranial Supratentorial Neoplasms

Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern—A first case‐series experience

“…Although the CRP level is a nonspecific inflammation marker and potentially influenced by bacterial coinfections and superinfections, which did not correlate with the number of lesions in chickenpox patients, 16 it could be a suitable additional marker for the assessment of the severity of MPX and to monitor treatment responses. 17 The severe MPX course in a UC patient treated with vedolizumab might be coincidental. However, vedolizumab is a recombinant antibody targeting the α 4 β 7 -integrin .…”

What is the optimal range of glycemic control for non‐diabetic patients undergoing gastroenterological surgery? A single‐center randomized controlled trial using an artificial pancreas

“…We also evaluated the factors associated with serum IL-6 levels. Based on previous studies, [20][21][22][23][24][25][26][27] we determined eight clinical items that should be evaluated as factors potentially associated with IL-6 levels. Nevertheless, multiple regression analysis did not demonstrate that these variables were associated with IL-6 on the 3POD.…”

“…Multiple regression analysis using the forced entry method was performed on exploratory analysis to identify the factors associated with IL‐6. Eight factors were used based on previous studies: amount of intraoperative blood loss (mL), 20 body mass index (BMI) (kg/m 2 ), 21 age at operation (years), 22 sex, 23 operation time (min), 24 mean blood glucose (mg/dl), 25 glycemic variability (mg/dL), 26 and the total amount of insulin administered (U) 27 . The standard deviation (SD) of glucose levels was used for glycemic variability.…”